RADIATION THERAPY ONCOLOGY GROUP
RTOG 0436
A PHASE III TRIAL EVALUATING THE ADDITION OF CETUXIMAB TO PACLITAXEL, CISPLATIN, AND RADIATION FOR PATIENTS WITH ESOPHAGEAL CANCER WHO ARE TREATED WITHOUT SURGERY
RTOG 0436
A PHASE III TRIAL EVALUATING THE ADDITION OF CETUXIMAB TO PACLITAXEL, CISPLATIN, AND RADIATION FOR PATIENTS WITH ESOPHAGEAL CANCER WHO ARE TREATED WITHOUT SURGERY
Protocol Participation Information
- Credentialing
- Facility Questionnaire: Part I and Part III are required for this protocol.
- A test of digital data submission is required for institutions that have not previously submitted external beam treatment planning data to the ITC. The treatment planning system to be used to plan patients on the study should be used for this digital data submission test. Please contact the ITC (itc@wustl.edu) for questions regarding digital data submission and to request an SFTP account, if you do not have one already.
- How to Participate
- Digital Data Submission Procedures
- Digital Data Submission Information (DDSI) Form
- ATC Compliant Treatment Planning Systems
- Structure Names
- Protocol Text (http://www.rtog.org)
Back to protocols
